All News #Library
Biotech
Behind Generate`s `feverish` race to raise $400M IPO
27 Feb 2026 //
FIERCE BIOTECH
Generate Plans $425M IPO To Bankroll Phase 3 Asthma Trials
23 Feb 2026 //
FIERCE BIOTECH
Generate Biomedicines Launches AI-Enhanced GB-0895 Trial
02 Dec 2025 //
PR NEWSWIRE
Flagship Brings AI Drug Discovery Firm Expedition Out Of Stealth
22 Oct 2025 //
FIERCE BIOTECH
Biomedicines To Unveil AI-Engineered Gb-0895 Phase 1 in Asthma
25 Sep 2025 //
PR NEWSWIRE
Biomedicines Highlights AI Platform, Pipeline at Morgan Conference
09 Jan 2025 //
PR NEWSWIRE

Market Place
Sourcing Support